ArticleItalian journal of pediatrics2026
Clinical, demographic and genetic features of pediatric limb-girdle muscular dystrophy in the Çukurova region.
Article in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimb Girdle Muscular Dystrophy (LGMD) is a heterogeneous group of muscle diseases that are common in childhood. This study aimed to determine the clinical, histopathological, genetic features characteristics of among pediatric patients with LGMD in the Çukurova region and to identify disease subgroups.
methodsThis study aimed to identify disease subgroups in the Çukurova region through a retrospective review of patients with LGMD, given differences in clinical indicators that can be used for early diagnosis and disease course as well as regional variations. Frequency and descriptive analyses were performed using SPSS 21 for Windows (IBM Corp., Armonk, NY, USA).
resultsThe most common type identified at our center was LGMD2A-R1 (51.6%). The other types were LGMD2F-R6, LGMD2D-R3 and LGMD2C-R5, in order of frequency. Among these subtypes, the earliest age of onset and diagnosis as well as the highest creatine kinase values, were observed in the LGMD2C-R5 group. Respiratory failure was notably frequent in patients with LGMD2F-R6. Early ambulation loss was detected in patients with LGMD2F-R6 and LGMD2D-R3. Muscle biopsy was performed on 9 of the 16 patients with calpainopathy and 12 of the 15 patients with sarcoglycanopathy. The diagnosis of LGMD was confirmed by genetic testing in 25 of 31 patients. Previously unidentified 3 new mutations were detected in 4 patients.
conclusionsEarly diagnosis and determination of LGMD subgroups are important for the investigation of targeted treatment options and the provision of genetic counseling in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.